Zomedica Depreciation And Amortization from 2010 to 2024

ZOM Stock  USD 0.17  0.01  5.56%   
Zomedica Pharmaceuticals Depreciation And Amortization yearly trend continues to be very stable with very little volatility. Depreciation And Amortization is likely to grow to about 6.6 M this year. Depreciation And Amortization is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. View All Fundamentals
 
Depreciation And Amortization  
First Reported
2016-06-30
Previous Quarter
1.6 M
Current Value
1.9 M
Quarterly Volatility
907.2 K
 
Covid
Check Zomedica Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zomedica main balance sheet or income statement drivers, such as Interest Expense of 183.8 K, Selling General Administrative of 30.5 M or Other Operating Expenses of 59.6 M, as well as many exotic indicators such as Price To Sales Ratio of 7.4, Dividend Yield of 0.0 or PTB Ratio of 0.78. Zomedica financial statements analysis is a perfect complement when working with Zomedica Pharmaceuticals Valuation or Volatility modules.
  
This module can also supplement various Zomedica Pharmaceuticals Technical models . Check out the analysis of Zomedica Pharmaceuticals Correlation against competitors.

Latest Zomedica Pharmaceuticals' Depreciation And Amortization Growth Pattern

Below is the plot of the Depreciation And Amortization of Zomedica Pharmaceuticals Corp over the last few years. It is the systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives. Zomedica Pharmaceuticals' Depreciation And Amortization historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Zomedica Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Depreciation And Amortization10 Years Trend
Slightly volatile
   Depreciation And Amortization   
       Timeline  

Zomedica Depreciation And Amortization Regression Statistics

Arithmetic Mean1,546,237
Geometric Mean259,363
Coefficient Of Variation169.66
Mean Deviation2,001,447
Median92,410
Standard Deviation2,623,374
Sample Variance6.9T
Range6.7M
R-Value0.77
Mean Square Error3T
R-Squared0.59
Significance0.0008
Slope450,735
Total Sum of Squares96.3T

Zomedica Depreciation And Amortization History

20246.6 M
20236.3 M
20226.7 M
20211.5 M
2020571.5 K
2019807.4 K
2018205.8 K

About Zomedica Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Zomedica Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Zomedica Pharmaceuticals investors use historical funamental indicators, such as Zomedica Pharmaceuticals's Depreciation And Amortization, to determine how well the company is positioned to perform in the future. Although Zomedica Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Zomedica Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Zomedica Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Zomedica Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Zomedica Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Depreciation And Amortization6.3 M6.6 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Zomedica Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Zomedica Pharmaceuticals is a strong investment it is important to analyze Zomedica Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zomedica Pharmaceuticals' future performance. For an informed investment choice regarding Zomedica Stock, refer to the following important reports:
Check out the analysis of Zomedica Pharmaceuticals Correlation against competitors.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for Zomedica Stock analysis

When running Zomedica Pharmaceuticals' price analysis, check to measure Zomedica Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zomedica Pharmaceuticals is operating at the current time. Most of Zomedica Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Zomedica Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zomedica Pharmaceuticals' price. Additionally, you may evaluate how the addition of Zomedica Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Is Zomedica Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zomedica Pharmaceuticals. If investors know Zomedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zomedica Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.04)
Revenue Per Share
0.026
Quarterly Revenue Growth
0.142
Return On Assets
(0.08)
Return On Equity
(0.15)
The market value of Zomedica Pharmaceuticals is measured differently than its book value, which is the value of Zomedica that is recorded on the company's balance sheet. Investors also form their own opinion of Zomedica Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Zomedica Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zomedica Pharmaceuticals' market value can be influenced by many factors that don't directly affect Zomedica Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zomedica Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Zomedica Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zomedica Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.